ReviewJournal of neurology2024

Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.

Barry A Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.